Word

CREYON

Status

Pending

Status Code

731

Status Date

Monday, March 11, 2024

Serial Number

90846010

Mark Type

4000

Filing Date

Friday, July 23, 2021

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

Creyon Bio, Inc. - Owner At Publication

Classifications

5 Diagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases

Trademark Events

Mar 12, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 11, 2024

Sou Extension 2 Granted

Mar 11, 2024

Sou Extension 2 Filed

Mar 11, 2024

Sou Teas Extension Received

Sep 22, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 20, 2023

Sou Extension 1 Granted

Sep 20, 2023

Sou Extension 1 Filed

Sep 20, 2023

Sou Teas Extension Received

Sep 15, 2023

Teas Change Of Correspondence Received

Sep 15, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 15, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 21, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 19, 2022

Approved For Pub - Principal Register

Nov 11, 2022

Teas/Email Correspondence Entered

Nov 11, 2022

Correspondence Received In Law Office

Nov 11, 2022

Teas Response To Office Action Received

May 12, 2022

Notification Of Non-Final Action E-Mailed

May 12, 2022

Non-Final Action E-Mailed

May 12, 2022

Non-Final Action Written

Apr 18, 2022

Assigned To Examiner

Sep 23, 2021

New Application Office Supplied Data Entered

Jul 27, 2021

New Application Entered